PMID- 30927195
OWN - NLM
STAT- In-Process
LR  - 20190511
IS  - 1534-4681 (Electronic)
IS  - 1068-9265 (Linking)
VI  - 26
IP  - 6
DP  - 2019 Jun
TI  - Compliance with Cancer Quality Measures Over Time and Their Association with
      Survival Outcomes: The Commission on Cancer's Experience with the Quality Measure
      Requiring at Least 12 Regional Lymph Nodes to be Removed and Analyzed with Colon 
      Cancer Resections.
PG  - 1613-1621
LID - 10.1245/s10434-019-07323-w [doi]
AB  - BACKGROUND: Many quality measures in cancer care are process measures. The rates 
      of compliance for these measures over time have not been well described, and the 
      relationships between measure compliance and survival are not well understood.
      METHODS: The National Cancer Database, representing cancer registry data from
      approximately 1500 Commission on Cancer (CoC) cancer programs, was queried to
      determine the rates of compliance, with the CoC's colon cancer quality measure
      requiring 12 regional lymph nodes be removed at resection. Data were assessed in 
      2003, before the measure was reported to programs, through 2015. Measure
      compliance and risk-adjusted survival were examined by hospital type. RESULTS:
      From 2003 to 2015, 544,018 cases of colon cancer were analyzed for number of
      nodes removed. In 2003, compliance was 52.8% and National Cancer Institute (NCI) 
      centers had the highest compliance rate (69.0%), followed by academic cancer
      centers (61.9%), comprehensive community hospitals (50.9%), and community
      hospitals (44.0%). Between 2003 and 2015, compliance improved for all hospital
      types, although differences remained. Risk-adjusted survival in 2009 was better
      at NCI centers [hazard ratio (HR) 0.76] than at academic cancer centers (HR
      0.90), which had better survivals than comprehensive community programs (HR 0.93)
      when compared with patients treated at community hospitals. CONCLUSION: After
      introduction of this quality measure, performance at CoC-accredited hospitals
      improved over the subsequent 13 years, and survival by hospital type paralleled
      measure compliance by hospital type. This demonstrated measurement may be
      associated with improvements in performance, and that there are differences in
      performance and outcome by hospital type.
FAU - Shulman, Lawrence N
AU  - Shulman LN
AD  - Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA, USA.
      Lawrence.shulman@uphs.upenn.edu.
AD  - American College of Surgeons, Commission on Cancer, Chicago, IL, USA.
      Lawrence.shulman@uphs.upenn.edu.
FAU - Browner, Amanda E
AU  - Browner AE
AD  - American College of Surgeons, Commission on Cancer, Chicago, IL, USA.
FAU - Palis, Bryan E
AU  - Palis BE
AD  - American College of Surgeons, Commission on Cancer, Chicago, IL, USA.
FAU - Mallin, Katherine
AU  - Mallin K
AD  - American College of Surgeons, Commission on Cancer, Chicago, IL, USA.
FAU - Kakade, Sumedh
AU  - Kakade S
AD  - Lankenau Medical Center, Wynnewood, PA, USA.
FAU - Carp, Ned
AU  - Carp N
AD  - American College of Surgeons, Commission on Cancer, Chicago, IL, USA.
AD  - Lankenau Medical Center, Wynnewood, PA, USA.
FAU - McCabe, Ryan
AU  - McCabe R
AD  - American College of Surgeons, Commission on Cancer, Chicago, IL, USA.
FAU - Winchester, David
AU  - Winchester D
AD  - American College of Surgeons, Commission on Cancer, Chicago, IL, USA.
FAU - Wong, Sandra L
AU  - Wong SL
AD  - American College of Surgeons, Commission on Cancer, Chicago, IL, USA.
AD  - Dartmouth Hitchcock Medical Center, Lebanon, NH, USA.
FAU - McKellar, Daniel P
AU  - McKellar DP
AD  - American College of Surgeons, Commission on Cancer, Chicago, IL, USA.
AD  - Wright State University, Dayton, OH, USA.
LA  - eng
PT  - Journal Article
DEP - 20190329
PL  - United States
TA  - Ann Surg Oncol
JT  - Annals of surgical oncology
JID - 9420840
EDAT- 2019/03/31 06:00
MHDA- 2019/03/31 06:00
CRDT- 2019/03/31 06:00
PHST- 2018/11/28 00:00 [received]
PHST- 2019/03/31 06:00 [pubmed]
PHST- 2019/03/31 06:00 [medline]
PHST- 2019/03/31 06:00 [entrez]
AID - 10.1245/s10434-019-07323-w [doi]
AID - 10.1245/s10434-019-07323-w [pii]
PST - ppublish
SO  - Ann Surg Oncol. 2019 Jun;26(6):1613-1621. doi: 10.1245/s10434-019-07323-w. Epub
      2019 Mar 29.